About
Charlotte Clay has over 20 years of experience in pharmaceutical testing to support all phases of drug product development from pre-clinical through to commercial release. She joined Quotient Sciences in 2009 and oversees the analytical development team at the Quotient Nottingham site primarily supporting the development of early phase drug products for Phase I clinical trials. Prior to joining Quotient Charlotte worked at Reckitt Benckiser and AstraZeneca. Her expertise includes working with poorly soluble molecules, modified release formulations and paediatric drug products, and the associated testing.
Expertise & focus areas
